Figure1
Provocholine Inhalation Solution
Product Images NDC 64281-116
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Provocholine Inhalation Solution (NDC 64281-116). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Methapharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Inner Carton Solution
This is a description of a medication called Provocholine, used as a diagnostic aid for bronchial airway hyperresponsiveness. It is administered through oral inhalation and comes in a carton containing six vials, each with different concentrations of methacholine chloride. The base solution contains no methacholine chloride. The solution is sterile and only for single use. Non-medicinal ingredients include sodium chloride, sodium acetate trihydrate, water for injection, and glacial acetic acid. The accompanying insert contains important use and warning information. It should be stored at 15 to 25°C. The medication is manufactured for Methapharm, Inc. and Provocholine is a registered trademark of Methapharm Inc.*
Inner Label 0.0625mgml
Description: Provocholine® Inhalation Solution is a medication containing methacholine chloride and is intended for oral inhalation use only. This is a single-dose medication and any unused portion should be discarded. The rest of the text seems to be illegible characters and not relevant to the description.*
Inner Label 0.25mgml
Provocholine® is an inhalation solution containing methacholine chloride. It has a concentration of 0.25mg/mL (0.75mg/3mL). It is for oral inhalation only and should be used as a single dose. Any unused portion should be discarded. The manufacturer is Methapharm, Inc. located in Coral Springs, FL 33065 USA.*
Inner Label 0mgml
This is a description of a 3mL base solution of Provocholine, a medication for oral inhalation that does not contain methacholine chloride. It is a single dose medication that should be discarded if not used. It was manufactured for Methapham, Inc. based in Coral Springs, Florida, USA.*
Inner Label 100mg
This is a mix of text that includes some numbers, letters, and symbols. Some of the text seems to refer to medical-related products and usage instructions, particularly regarding Methacholine Chloride powder for oral inhalation use. However, most of the text is not legible or understandable, so it cannot provide a useful description.*
Inner Label 16mgml
Provocholine® is a medication available in inhalation solution form containing methacholine chloride in a concentration of 16mg/mL (48mg/3mL). It is intended for oral and inhalation use as a single dose. Unused portions should be discarded. Lot numbers and expiration dates are not available from the provided text.*
Inner Label 1mgml
Provocholme® is an inhalation solution containing methacholine chloride, with a concentration of 1mg/mL (@mg/3ml), intended for oral inhalation only. The solution is sterile and should be used as a single dose. Any unused portion should be discarded. The product is manufactured by Methapharm Inc. located in Coral Springs, FL 33065, USA.*
Inner Label 4mgml
This appears to be the label of an medication called Provocholme Inhalation Solution which contains methacholine chloride. It is a single dose inhalation solution with a concentration of 4mg/mL and comes in a container of 3mL. The medication is intended for oral inhalation only and after use, any remaining solution should be discarded. The label also includes a lot number and expiration date.*
Methapharm
Outer Carton 100mg
Outer Carton Solution
Methapharm produces Provocholine, an inhalation solution for bronchial challenge testing known as Methacholine Challenge Testing. The product helps physicians diagnose asthma by administering doses of Methacholine to the patient to test the airway's responsiveness, a part of diagnosing Asthma. The text also includes the date of May 5th, 2022.*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
